[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@KymeraTx Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::865299019752452096.png) @KymeraTx Kymera Therapeutics

Kymera Therapeutics posts on X about kymera, $kymr, culture, events the most. They currently have XXXXX followers and XX posts still getting attention that total XXXXX engagements in the last XX hours.

### Engagements: XXXXX [#](/creator/twitter::865299019752452096/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::865299019752452096/c:line/m:interactions.svg)

- X Week XXXXXX +818%
- X Month XXXXXX +165%
- X Months XXXXXX +255%
- X Year XXXXXX +254%

### Mentions: X [#](/creator/twitter::865299019752452096/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::865299019752452096/c:line/m:posts_active.svg)

- X Week XX +27%
- X Month XX +35%
- X Months XX +117%
- X Year XX +407%

### Followers: XXXXX [#](/creator/twitter::865299019752452096/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::865299019752452096/c:line/m:followers.svg)

- X Week XXXXX +0.32%
- X Month XXXXX +0.40%
- X Months XXXXX +3.10%
- X Year XXXXX +4.20%

### CreatorRank: XXXXXXX [#](/creator/twitter::865299019752452096/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::865299019752452096/c:line/m:influencer_rank.svg)

### Social Influence

**Social category influence**
[finance](/list/finance)  XXXX%

**Social topic influence**
[kymera](/topic/kymera) #3, [$kymr](/topic/$kymr) #15, [culture](/topic/culture) 21.43%, [events](/topic/events) 7.14%, [the first](/topic/the-first) 7.14%, [the world](/topic/the-world) 7.14%, [ceo](/topic/ceo) 7.14%, [science](/topic/science) XXXX%

**Top accounts mentioned or mentioned by**
[@nellomainolfi](/creator/undefined) [@stifel](/creator/undefined) [@jefferies](/creator/undefined) [@pipersandler](/creator/undefined) [@citi](/creator/undefined) [@bostonglobe](/creator/undefined) [@thepharmaletter](/creator/undefined)

**Top assets mentioned**
[Kymera Therapeutics, Inc. Common Stock (KYMR)](/topic/$kymr)
### Top Social Posts
Top posts by engagements in the last XX hours

"From savoring delicious foods to dancing and singing our recent #Diwali festival of lights celebration brought joy and color to Kymera🪔🎶💃 These moments remind us how special it is to work in a community where every person brings their own rhythm flavor and story - a true reflection of the rich traditions that make our workplace shine.✨ #Belong #Culture #EmployeeExperience"  
[X Link](https://x.com/KymeraTx/status/1991490354663584180)  2025-11-20T12:54Z 3464 followers, XXX engagements


"$KYMR Explore our upcoming investor events in December in our latest press release:"  
[X Link](https://x.com/KymeraTx/status/1992927158214480264)  2025-11-24T12:03Z 3464 followers, XXX engagements


"Were pleased to share that the first patient has been dosed in our BROADEN2 Phase 2b clinical trial evaluating KT-621 our investigational first-in-class oral STAT6-targeted medicine for moderate to severe atopic dermatitis. This milestone underscores our commitment to advancing novel oral therapies for patients. Read the full announcement: #RevolutionizingImmunology #BROADEN2 #AtopicDermatitis #Eczema $KYMR"  
[X Link](https://x.com/KymeraTx/status/1993289634462261482)  2025-11-25T12:04Z 3464 followers, 1195 engagements


"🦃This Thanksgiving we celebrated gratitude in the sweetest way with handwritten notes and Kymerathemed cookies because teamwork is the recipe for success and appreciation is always in season 💌 Were thankful every day for the incredible Kymera team whose dedication drives our mission to advance innovative oral medicines for patients around the world. #Belong #Culture #HappyThanksgiving"  
[X Link](https://x.com/KymeraTx/status/1993743778432078082)  2025-11-26T18:08Z 3474 followers, XXX engagements


"Today at the @Piper_Sandler 37th Annual Healthcare Conference our CEO @NelloMainolfi will discuss Kymera's groundbreaking work in immunology and highlight key upcoming milestones. Live webcast available here: $KYMR #RevolutionizingImmunology"  
[X Link](https://x.com/KymeraTx/status/1995848107180130385)  2025-12-02T13:30Z 3476 followers, XXX engagements


"Today at the@Citi 2025 Global Healthcare Conference our CMOJared Gollob will share our vision for transforming treatment paradigms in immunology listen to the live webcast $KYMR #RevolutionizingImmunology"  
[X Link](https://x.com/KymeraTx/status/1996203076253089875)  2025-12-03T13:01Z 3476 followers, XXX engagements


"Join our CMO Jared Gollob for his fireside chat at the Evercore 8th Annual Healthcare Conference to learn more about our industry-leading pipeline of oral degrader programs. Join the live webcast #RevolutionizingImmunolgy"  
[X Link](https://x.com/KymeraTx/status/1996566174428168554)  2025-12-04T13:04Z 3476 followers, XXX engagements


"Were proud to share that Kymera has been named a @BostonGlobe Top Place to Work for the fourth year in a row And its all thanks to our incredible team. Our exceptional people power everything: bold science backed by a culture where everyone can grow collaborate co-create and make a meaningful impact. This recognition reflects the energy and heart our employees bring every day as we work to revolutionize care in immunology. Want to see what makes our community so special Hear directly from the team in the video below. #RevolutionizingImmunology #TopPlacesToWork"  
[X Link](https://x.com/KymeraTx/status/1996701763290775914)  2025-12-04T22:02Z 3476 followers, 1234 engagements


"Were excited to announce positive results from our BroADen Phase 1b clinical trial of KT-621 our investigational first-in-class oral STAT6 degrader in patients with moderate to severe atopic dermatitis. The data provide a powerful validation of our industry-leading STAT6 degrader program and help accelerate our goal to deliver novel oral medicines to millions of patients around the world. Our deepest thanks to the patients investigators and the incredible Kymera team whose dedication made this significant milestone possible. Read more about the promising KT-621 data in our press release and"  
[X Link](https://x.com/KymeraTx/status/1998001677601828955)  2025-12-08T12:08Z 3476 followers, 13K engagements